Related Experiment Video

Updated: Mar 3, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

Hypoperfusion in early-phase amyloid PET as a predictor of cognitive decline in Alzheimer's disease

A Škorvagová1, F Ribaldi2,3, J Cerman4

  • 1Memory Clinic, Department of Neurology, Charles University in Prague, 2Nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.

European Journal of Nuclear Medicine and Molecular Imaging
|March 1, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Alzheimer diseaseAmyloid PETCerebral perfusionCognitive declineEarly-phase imagingPrognostic biomarker

More Related Videos

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.7K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.1K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K